In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Host:
Josep Tabernero, MD, PhD
Head, Medical Oncology Department
Director, Vall d’Hebron Institute of Oncology (VHIO)
Professor of Medicine, UVic-UCC
Vall d’Hebron University Hospital (HUVH)
Barcelona, Spain
Dr. Tabernero has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Alentis Therapeutics, AstraZeneca, Aveo Oncology, Boehringer Ingelheim, Cardiff Oncology, CARSgen Therapeutics, Chugai, Daiichi Sankyo, F. Hoffmann-La Roche Ltd, Genentech Inc, hC Bioscience, Ikena Oncology, Immodulon Therapeutics, Inspirna Inc, Lilly, Menarini, Merck Serono, Merus, MSD, Mirati, Neophore, Novartis, Ona Therapeutics, Orion Biotechnology, Peptomyc, Pfizer, Pierre Fabre, Samsung Bioepis, Sanofi, Scandion Oncology, Scorpion Therapeutics, Seattle Genetics, Servier, Sotio Biotech, Taiho, Takeda Oncology and Tolremo Therapeutics
Ownership: Oniria Therapeutics, Alentis Therapeutics, Pangaea Oncology and 1TRIALSP
Faculty:
Sara Lonardi, MD
Chief, Oncology Unit 3
Veneto Institute of Oncology – IRCCS
Padua, Italy
Dr. Lonardi has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Amgen, Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Daiichi Sankyo, Inc., Incyte, Lilly, Merck Serono, MSD, Pierre-Fabre, Roche, Rottapharm, Servier, Takeda
Research: Amgen, Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Daiichi Sankyo, Hutchinson, Incyte, Merck Serono, Mirati, MSD, Pfizer, Roche, Servier
Zev A. Wainberg, MD
Co-Director, UCLA GI Oncology Program
Professor of Medicine
University of California, Los Angeles
Santa Monica, CA, USA
Dr. Wainberg has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Alligator, Amgen, Arcus, Astellas, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Inc., Gilead, Ipsen, Janssen, Merck, Novartis, Regeneron, Roche/Genentech
Research: Amgen, Arcus, AstraZeneca, BMS, Merck, and Novartis
Reviewers/Content Planners/Authors:
- Jorge Bacigalupo has nothing to disclose.
- Brad Bongiovanni, ND, has nothing to disclose.
- Cindy Davidson has nothing to disclose.
- Ann Early has nothing to disclose.
- Wendy Engelsma has nothing to disclose.
- Andrea Mathis has nothing to disclose.
- Bing-E Xu, PhD, has nothing to disclose.
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should claim only the credit commensurate with the extent of their participation in the activity.
